Push launch MHRA approves GLP –1 receptor agonist semaglutide to cut back chance of serious heart challenges in obese or overweight Grownups Semaglutide is the 1st weight-loss drug accepted in the UK being a preventative treatment for people with founded cardiovascular disease Be sure to Ke